Phloretin

Phloretin

SCHEMBL1506325

O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O.O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 7/20 1.00
SLC5A2 P31639 7/20 1.00
CYP19A1 P11511 4/20 1.00
MAPT P10636 3/20 1.00
HSD17B10 Q99714 3/20 1.00
GAA P10253 2/20 1.00
NFKB1 P19838 2/20 1.00
NFKB2 Q00653 2/20 1.00
RELA Q04206 2/20 1.00
SLC28A3 Q9HAS3 2/20 1.00
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 2/20 1.00
THRB P10828 2/20 1.00
CYP2C9 P11712 2/20 1.00
HPGD P15428 2/20 1.00
CYP2C19 P33261 2/20 1.00
MEN1 O00255 1/20 1.00
SLC16A3 O15427 1/20 1.00
ALDH1A1 P00352 1/20 1.00
LMNA P02545 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phloretin SCHEMBL38131 1.00 SLC5A1 (1.00) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL31684375 0.98 SLC5A1 (0.96) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL30912872 0.98 SLC5A1 (0.96) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL30785809 0.98 SLC5A1 (0.96) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL27910960 0.96 SLC5A1 (0.93) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL28362318 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL30603791 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL21192491 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL6402644 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL27906064 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108060165-B Alpha-subunit-combined F1F0-ATP synthetase RNA inhibitor and application thereof 浙江大学 2021-03-02 CN disclosed
CN-108486117-B RNA inhibitor and application thereof in inhibiting activity of F1F0-ATP synthetase 浙江大学 2020-09-08 CN disclosed
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed
CN-107694704-B A kind of chemical industry prepares raw material grinding device with phloretin 东营明德化工有限公司 2019-06-14 CN disclosed
CN-108486117-A A kind of RNA inhibitor and its application in inhibiting F1F0-ATP synthase activities 浙江大学 2018-09-04 CN disclosed
CN-108384814-A A kind of preparation method of phloretin 重庆大学 2018-08-10 CN disclosed
CN-108060165-A A kind of F1F0-ATP synthetase RNA (Ribonucleic Acid)s inhibitor of combination α subunits and application 浙江大学 2018-05-22 CN disclosed
CN-107694704-A A kind of chemical industry phloretin preparing raw material reducing mechanism 徐州蓝湖信息科技有限公司 2018-02-16 CN disclosed
WO-2017187352-A1 MOFEZOLAC DERIVATIVES AS MULTI-FUNCTIONS SELECTIVE COX-1 INHIBITORS UNIVERSITA' DEGLI STUDI DI BARI "ALDO MORO" (IT) 2017-11-02 WO disclosed
CN-104825452-B The application of urea hydrolytic velocity inhibitor 北京大学 2017-08-11 CN disclosed
CN-104825452-A Application of urea transporter (UT) inhibitor Youli UNIV BEIJING 2015-08-12 CN disclosed
US-20110076239-A1 REDUCED-SWEETENER PRODUCTS, FLAVORING MIXTURES FOR SAID REDUCED-SWEETENER PRODUCTS AND PROCESS FOR THE PRODUCTION OF PRODUCTS OF THIS TYPE SYMRISE AG (DE) 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076239-A1 REDUCED-SWEETENER PRODUCTS, FLAVORING MIXTURES FOR SAID REDUCED-SWEETENER PRODUCTS AND PROCESS FOR THE PRODUCTION OF PRODUCTS OF THIS TYPE TAS2R30, TAS2R40, TAS2R60 SLC5A1 67/4885SLC5A2 32/4885CYP19A1 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.